EPO and type 2 diabetes mellitus: Interestingly, in T2DM patients treated with dapagliflozin, erythropoietin (EPO) levels remained elevated even after two months, suggesting that hematocrit increases result from both diuretic-induced hemoconcentration and enhanced EPO production [147].